TY - JOUR
T1 - Prospective assessment of anxiety among pediatric oncology patients and their caregivers during the COVID-19 pandemic a cohort study
AU - Yaffe Ornstein, Michal
AU - Friedlander, Edwa
AU - Katz, Shir
AU - Elhasid, Ronit
N1 - Publisher Copyright:
© 2022 Taylor & Francis Group, LLC.
PY - 2023
Y1 - 2023
N2 - Objective: To assess COVID-19-pandemic related anxiety and emotional-behavioral difficulties among oncologic children and their caregivers. Design: Prospective cohort study conducted from March to November 2020. Participants: 76 pediatric oncological and 28 nonmalignant hematological patients aged 1.6–23.4 years and their caregivers. Methods: A total of 104 families completed an age-specific self-report psychological assessment; of these, 20 oncologic families completed the assessment at two time points. Findings: Ten percent of the caregivers and 13.9% of the patients reported anxiety disorder. Additionally, 3.1% of the caregivers reported behavioral difficulties. No significant differences emerged between patients’ self-reports and caregivers’ reports. No differences emerged between oncological and nonmalignant hematological participants. Conclusions: The prevalence of anxiety associated with the COVID-19 pandemic was similar to the reported prevalence of anxiety following a diagnosis of pediatric malignancy. Implications: Real-time assessment of psychological effects revealed no COVID-19-associated anxiety. Nonetheless, late effects will need to be monitored.
AB - Objective: To assess COVID-19-pandemic related anxiety and emotional-behavioral difficulties among oncologic children and their caregivers. Design: Prospective cohort study conducted from March to November 2020. Participants: 76 pediatric oncological and 28 nonmalignant hematological patients aged 1.6–23.4 years and their caregivers. Methods: A total of 104 families completed an age-specific self-report psychological assessment; of these, 20 oncologic families completed the assessment at two time points. Findings: Ten percent of the caregivers and 13.9% of the patients reported anxiety disorder. Additionally, 3.1% of the caregivers reported behavioral difficulties. No significant differences emerged between patients’ self-reports and caregivers’ reports. No differences emerged between oncological and nonmalignant hematological participants. Conclusions: The prevalence of anxiety associated with the COVID-19 pandemic was similar to the reported prevalence of anxiety following a diagnosis of pediatric malignancy. Implications: Real-time assessment of psychological effects revealed no COVID-19-associated anxiety. Nonetheless, late effects will need to be monitored.
KW - COVID-19
KW - anxiety
KW - caregivers
KW - oncology
KW - pediatric
KW - psychological assessment
UR - http://www.scopus.com/inward/record.url?scp=85131925678&partnerID=8YFLogxK
U2 - 10.1080/07347332.2022.2086092
DO - 10.1080/07347332.2022.2086092
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35703090
AN - SCOPUS:85131925678
SN - 0734-7332
VL - 41
SP - 182
EP - 195
JO - Journal of Psychosocial Oncology
JF - Journal of Psychosocial Oncology
IS - 2
ER -